Christopher Kilburn-Peterson was promoted to corporate vice president and president of the Tissue Reconstruction division and Robert T. Davis Jr. was named executive vice president of Tissue Reconstruction and Distributed Technologies. Harvinder Singh became executive vice president and president of Specialty Surgery reporting to chief commercial officer Mike McBreen.
Christopher Kilburn-Peterson was promoted to corporate vice president and president of the Tissue Reconstruction division, Robert T. Davis Jr. was named executive vice president of Tissue Reconstruction and Distributed Technologies, and Harvinder Singh became executive vice president and president of the Specialty Surgery division.
All three executives now report under chief commercial officer Mike McBreen, with Kilburn-Peterson and Davis focusing on wound reconstruction, soft tissue and private label segments, and Singh leading commercial and portfolio strategy for surgical products.
These appointments aim to deepen leadership bench strength, enhance customer engagement and accelerate commercial execution across key business units to support Integra LifeSciences’ long-term growth objectives.
